Venous thromboembolism Risk of recurrence lower with rivaroxaban than aspirin

被引：0
|
作者：
Huynh, Karina
机构：
来源：
NATURE REVIEWS CARDIOLOGY | 2017年 / 14卷 / 05期
关键词：
D O I：
10.1038/nrcardio.2017.41
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [41] Risk of recurrence of venous thromboembolism in patients with gynaecological cancer
    Marchocki, Z.
    Abu Saadeh, F.
    Gleeson, N.
    Norris, L.
    THROMBOSIS RESEARCH, 2017, 151 : S133 - S133
  • [42] Aspirin for Prevention of Thromboembolism Recurrence
    Edwards, Charles
    Taylor, Stephanie
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (11): : 1067 - 1067
  • [43] Assessment of Recurrence Risk After Unprovoked Venous Thromboembolism
    Rodger, Marc A.
    Ramsay, Timothy
    Le Gal, Gregoire
    Carrier, Marc
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (09) : 644 - 644
  • [44] Clinical scores to predict recurrence risk of venous thromboembolism
    Kyrle, Paul A.
    Eichinger, Sabine
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (06) : 1061 - 1064
  • [45] After initial anticoagulation for a first unprovoked venous thromboembolism, aspirin reduced recurrence
    Dunn, Andrew S.
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (04)
  • [46] Aspirin for Preventing the Recurrence of Venous Thromboembolism (vol 366, pg 1959, 2012)
    Becattini, Cecilia
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (16): : 1573 - 1573
  • [47] Aspirin and recurrent venous thromboembolism
    Prandoni, P.
    Noventa, F.
    Milan, M.
    PHLEBOLOGY, 2013, 28 : 99 - 104
  • [48] Aspirin and the Prevention of Venous Thromboembolism
    Becker, Richard C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2028 - 2030
  • [49] Aspirin for Preventing Venous Thromboembolism
    Culic, Viktor
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08): : 772 - 772
  • [50] Recurrence of malignancy-associated venous thromboembolism among patients treated with rivaroxaban compared to enoxaparin
    Nicklaus, Megan D.
    Ludwig, Shannon L.
    Kettle, Jacob K.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (03) : 185 - 189
12345